Lingering symptoms have been reported by Ebola virus disease (EVD) survivors in Africa over the past few years.
For example, the Liberian Ebola Survivors Cohort study published on September 6, 2022, found headache, fatigue, joint pain, muscle pain, hearing loss, visual loss, and numbness of hands or feet were longitudinally assessed among EVD participants.
At baseline, about 75% reported at least one symptom, and 85% significantly interfered with life.
Long-Ebola Needs Extensive Research
Telehealth Services Use for Opioid Use Disorder Rose During Pandemic
More Medicare beneficiaries received OUD-related telehealth services, behavioral health-related telehealth services, meds for OUD
Twelfth Version of Living Guideline Issued for Drugs for COVID-19
New update strongly recommends against use of sotrovimab and casirivimab-imdevimab for patients with COVID-19
Full-Dose Anticoagulation Beneficial for Critically Ill With COVID-19
However, no significant difference seen in efficacy or safety outcomes for clopidogrel versus no antiplatelet therapy